FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803273095> ?p ?o ?g. }

• W2803273095 endingPage "467" @default.
• W2803273095 startingPage "455" @default.
• W2803273095 abstract "Stimulant medications for the treatment of attention-deficit/hyperactivity disorder have a history of safe and effective use; however, concerns exist that they may adversely affect growth trajectories in children and adolescents. The objective of this study was to evaluate the longer-term effects of lisdexamfetamine dimesylate on weight, height, body mass index and pubertal development in children and adolescents with attention-deficit/hyperactivity disorder. Children and adolescents aged 6–17 years with attention-deficit/hyperactivity disorder took open-label lisdexamfetamine dimesylate (30, 50 or 70 mg/day) in this open-label 2-year safety and efficacy study. Safety evaluations included treatment-emergent adverse events, measurement of weight, height and body mass index, and self-reported pubertal status using Tanner staging. The safety analysis population comprised all enrolled participants (N = 314) and 191 (60.8%) completed the study. Weight decrease was reported as a treatment-emergent adverse event in 63 participants (20.1%) and two participants (0.6%) discontinued the study as a result of treatment-emergent adverse events of weight decrease. Growth retardation of moderate intensity was reported as a treatment-emergent adverse event for two participants. From baseline to the last on-treatment assessment, there were increases in mean weight of 2.1 kg (standard deviation 5.83) and height of 6.1 cm (standard deviation 4.90), and a body mass index decrease of 0.5 kg/m2 (standard deviation 1.72). Mean weight, height and body mass index z-scores decreased over the first 36 weeks of the study and then stabilised. Changes from baseline to the last on-treatment assessment in mean z-scores for weight, height and body mass index were significantly less than zero (− 0.51, − 0.24 and − 0.59, respectively; nominal p < 0.0001). The proportion of participants with a z-score of < − 1 ranged from 5.1% (baseline) to 22.1% (week 84) for weight, 8.2% (baseline) to 12.6% (week 96) for height, and 8.3% (baseline) to 28.8% (week 96) for body mass index. Thirteen participants (4.1%) shifted to a weight below the fifth percentile at the last on-treatment assessment from a higher weight category at baseline. At the last on-treatment assessment, most participants remained at their baseline Tanner stage or had shifted higher. Findings from this comprehensive examination of growth outcomes associated with lisdexamfetamine dimesylate treatment over 2 years were consistent with previous studies of stimulant medications. Whilst mean weight and height increased over the course of the study, there was a small but transient reduction in mean weight, height and body mass index z-scores. A small increase in the proportion of participants in the lowest weight and body mass index categories highlights the importance of the regular monitoring of weight and height. There was no evidence of delayed onset of puberty. NCT01328756." @default.
• W2803273095 created "2018-06-01" @default.
• W2803273095 creator A5001822053 @default.
• W2803273095 creator A5016008616 @default.
• W2803273095 creator A5024672699 @default.
• W2803273095 creator A5052792299 @default.
• W2803273095 creator A5053477956 @default.
• W2803273095 creator A5066566865 @default.
• W2803273095 creator A5070385935 @default.
• W2803273095 creator A5076676344 @default.
• W2803273095 date "2018-05-01" @default.
• W2803273095 modified "2023-09-26" @default.
• W2803273095 title "Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder" @default.
• W2803273095 cites W1965561480 @default.
• W2803273095 cites W1966223858 @default.
• W2803273095 cites W1985935801 @default.
• W2803273095 cites W1994733566 @default.
• W2803273095 cites W1999797036 @default.
• W2803273095 cites W2002339267 @default.
• W2803273095 cites W2008409978 @default.
• W2803273095 cites W2010667681 @default.
• W2803273095 cites W2013338353 @default.
• W2803273095 cites W2024532533 @default.
• W2803273095 cites W2025723107 @default.
• W2803273095 cites W2028637191 @default.
• W2803273095 cites W2032172480 @default.
• W2803273095 cites W2046668977 @default.
• W2803273095 cites W2051714695 @default.
• W2803273095 cites W2053105417 @default.
• W2803273095 cites W2057962659 @default.
• W2803273095 cites W2069755605 @default.
• W2803273095 cites W2077454035 @default.
• W2803273095 cites W2082384177 @default.
• W2803273095 cites W2084764358 @default.
• W2803273095 cites W2086997214 @default.
• W2803273095 cites W2087928748 @default.
• W2803273095 cites W2108571276 @default.
• W2803273095 cites W2111560477 @default.
• W2803273095 cites W2124380553 @default.
• W2803273095 cites W2129620184 @default.
• W2803273095 cites W2131679908 @default.
• W2803273095 cites W2165776786 @default.
• W2803273095 cites W2171589158 @default.
• W2803273095 cites W2312070181 @default.
• W2803273095 cites W2325694377 @default.
• W2803273095 cites W2391879726 @default.
• W2803273095 cites W2594813461 @default.
• W2803273095 cites W2601578636 @default.
• W2803273095 cites W2733319408 @default.
• W2803273095 cites W4235431946 @default.
• W2803273095 cites W76668800 @default.
• W2803273095 doi "https://doi.org/10.1007/s40263-018-0514-8" @default.
• W2803273095 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5976689" @default.
• W2803273095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29790103" @default.
• W2803273095 hasPublicationYear "2018" @default.
• W2803273095 type Work @default.
• W2803273095 sameAs 2803273095 @default.
• W2803273095 citedByCount "11" @default.
• W2803273095 countsByYear W28032730952018 @default.
• W2803273095 countsByYear W28032730952019 @default.
• W2803273095 countsByYear W28032730952020 @default.
• W2803273095 countsByYear W28032730952021 @default.
• W2803273095 countsByYear W28032730952023 @default.
• W2803273095 crossrefType "journal-article" @default.
• W2803273095 hasAuthorship W2803273095A5001822053 @default.
• W2803273095 hasAuthorship W2803273095A5016008616 @default.
• W2803273095 hasAuthorship W2803273095A5024672699 @default.
• W2803273095 hasAuthorship W2803273095A5052792299 @default.
• W2803273095 hasAuthorship W2803273095A5053477956 @default.
• W2803273095 hasAuthorship W2803273095A5066566865 @default.
• W2803273095 hasAuthorship W2803273095A5070385935 @default.
• W2803273095 hasAuthorship W2803273095A5076676344 @default.
• W2803273095 hasBestOaLocation W28032730951 @default.
• W2803273095 hasConcept C118552586 @default.
• W2803273095 hasConcept C126322002 @default.
• W2803273095 hasConcept C15744967 @default.
• W2803273095 hasConcept C187212893 @default.
• W2803273095 hasConcept C197934379 @default.
• W2803273095 hasConcept C2780221984 @default.
• W2803273095 hasConcept C2780557958 @default.
• W2803273095 hasConcept C2780783007 @default.
• W2803273095 hasConcept C2908647359 @default.
• W2803273095 hasConcept C71924100 @default.
• W2803273095 hasConcept C99454951 @default.
• W2803273095 hasConceptScore W2803273095C118552586 @default.
• W2803273095 hasConceptScore W2803273095C126322002 @default.
• W2803273095 hasConceptScore W2803273095C15744967 @default.
• W2803273095 hasConceptScore W2803273095C187212893 @default.
• W2803273095 hasConceptScore W2803273095C197934379 @default.
• W2803273095 hasConceptScore W2803273095C2780221984 @default.
• W2803273095 hasConceptScore W2803273095C2780557958 @default.
• W2803273095 hasConceptScore W2803273095C2780783007 @default.
• W2803273095 hasConceptScore W2803273095C2908647359 @default.
• W2803273095 hasConceptScore W2803273095C71924100 @default.
• W2803273095 hasConceptScore W2803273095C99454951 @default.
• W2803273095 hasIssue "5" @default.
• W2803273095 hasLocation W28032730951 @default.
• W2803273095 hasLocation W28032730952 @default.

• next